| Literature DB >> 28381755 |
Fumio Yamamoto1, Satoshi Yamashita, Hiroyuki Kawano, Tomio Tanigawa, Yosuke Mihara, Toru Gonoi, Yukio Ando.
Abstract
A 73-year-old man was admitted to our hospital with disturbance of consciousness, fever and headache. Cerebrospinal fluid (CSF) analysis revealed pleocytosis with neutrophil predominance, increased protein and low glucose. CSF and blood cultures yielded negative results. Antibiotics and antituberculous drugs were started for meningitis. An antimycotic was also added. The patient died from transtentorial hernia 99 days after admission. Autopsy revealed meningitis, ventriculitis and brain abscess, and Nocardia araoensis was detected in pus from the left lateral ventricle. This appears to represent the first report of N. araoensis meningitis complicated by ventriculitis and brain abscess.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28381755 PMCID: PMC5457932 DOI: 10.2169/internalmedicine.56.7332
Source DB: PubMed Journal: Intern Med ISSN: 0918-2918 Impact factor: 1.271
Timeline of CSF Analyses.
| 1st analysis (day 4) | 2nd analysis (day 10) | 3rd analysis (day 18) | 4th analysis (day 29) | 5th analysis (day 50) | 6th analysis (day 80) | |
|---|---|---|---|---|---|---|
| CSF cell count (/μL) | 1244 | 802 | 128 | 40 | 1311 | 268 |
| (poly:mono, %) | (90 : 10) | (90 : 10) | (83 : 17) | (65 : 35) | (85 : 15) | (86 : 14) |
| CSF glucose (mg/dL) | 47 | 34 | 38 | 41 | 44 | 34 |
| Simultaneous blood glucose (mg/dL) | 141 | not done | not done | 101 | not done | 104 |
| CSF protein (mg/dL) | 273 | 196 | 117 | 152 | 753 | 715 |
Moderately decreased glucose levels and neutrophil-dominant pleocytosis are seen in all CSF analyses throughout the clinical course.
Figure 1.Timeline of the clinical course. The patient was treated for fungal meningitis. Antituberculous drugs and antibiotics were also administered, but not continuously. His condition gradually deteriorated and death from transtentorial hernia occurred on day 99. CTM: cefotiam, CTRX: ceftriaxone, EB: ethambutol, INH: isoniazid, L-AMB: liposomal amphotericin-B, MEPM: meropenem, MINO: minocycline, PAMP/BP: panipenem/betamipron, PIPC: piperacillin, RFP: rifampicin, VCM: vancomycin
Figure 2.MRI on days 14, 50 and 71. A) MRI on day 14 shows a DWI hyperintense spot in the posterior horn of the left lateral ventricle (arrow). B) The lesion is iso-intense on ADC. C) On FLAIR, a hyperintense lesion is apparent in the white matter adjacent to the posterior horn of the left lateral ventricle (arrow). D, G) DWI on days 50 and 71 reveals gradual deterioration of ventriculitis (arrows). E, H) ADC mapping, the area of the DWI-hyperintense lesion appears partially hypointense (arrows). F, I) Spread of the FLAIR-hyperintense lesion in the white matter adjacent to the ventricles (arrows).
Figure 3.Autopsy findings. A) Yellowish pus is seen flowing from a ventricle (arrow). B) Gram staining of pus from the ventricle reveals a delicate, branching, filamentous organism. C) Pus is scattered throughout the basal cistern and pontomedullary cistern (arrows). D) In formalin-fixed brain sections, both lateral ventricles are full of pus (arrows). E) Magnification of the outlined square in D shows some small abscesses in the cerebral white matter (arrows).
Results of Minimal Inhibitory Concentration (MIC) Testing for Antibiotics.
| antibiotics | MIC (μg/mL) |
|---|---|
| AMK | <0.5 (susceptible) |
| CTRX | <2 (susceptible) |
| CPFX | 4 (resistant) |
| IPM | 4 (susceptible) |
| LZD | 4 (susceptible) |
| MINO | 2 (intermediate) |
| ST | 9.5/0.5 (susceptible) |
| TOB | <0.5 (susceptible) |
| CTX | <2 (susceptible) |
| CFPM | 4 (susceptible) |
| DOXY | 8 (resistant) |
| GM | <0.5 (susceptible) |
| CAM | <0.25 (susceptible) |
The present strain of N. araoensis was resistant to DOXY and CPFX, with intermediate susceptibility to MINO. AMK: amikacin sulfate, CTRX: ceftriaxone, CPFX: ciprofloxacin, IMP: imipenem/cilastatin, LZD: linezolid, MINO: minocycline, ST: sulfamethoxazole/trimethoprim, TOB: tobramycin, CTX: cefotaxime, CFPM: cefepim, DOXY: doxycycline hydrochloride, GM: gentamycin, CAM: clarithromycin